GlassScriptPhysician profile
Paul D Kim
NPI 1639336043
$79,802.15
in general payments reported to CMS, 2019-2025
33 companies · $6,053 in 2025
The $6,053 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $30K · 2021: $10K · 2022: $3,955 · 2023: $1,050 · 2024: $1,854 · 2025: $6,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,358 · Consulting Fee: $3,000 · Travel and Lodging: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,357.51 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $1,599.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $23,208.91 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Magnify |
| Surgalign Spine Technologies, INC. | $19,145.93 | 2020-2022 | |
| Spinal Elements, INC. | $11,888.25 | 2019-2020 | |
| Elutia, INC. | $9,750.68 | 2019-2023 | |
| Nuvasive, INC. | $4,734.41 | 2019-2020 | |
| Intrinsic Therapeutics | $3,479.59 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $2,949.95 | 2024-2025 | Cd Horizon Spinal System, Intellis Adaptivestim, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Nevro Corp. | $884.25 | 2020-2023 | Senza |
| Alphatec Spine, INC | $538.54 | 2022-2023 | Biologics |
| Boston Scientific Corporation | $466.08 | 2021-2025 | Infinion 16, Intracept |
| Zimmer Biomet Holdings, INC. | $335.47 | 2020-2021 | |
| Medtronic USA, INC. | $268.76 | 2019-2020 | |
| Si-Bone, INC. | $260.97 | 2019-2025 | |
| Orthofix Medical, INC. | $229.74 | 2022-2025 | Spinal-Stim |
| Depuy Synthes Sales INC. | $225.38 | 2019-2023 | Orthovisc |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $214.01 | 2024-2025 | Prodisc L, Prodisc C Vivo |
| Curonix LLC | $196.79 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $157.21 | 2022 | |
| Baxter Healthcare | $151.42 | 2019-2022 | |
| Stryker Corporation | $134.15 | 2019 | |
| Stimwave Technologies Incorporated | $132.67 | 2019 | |
| Djo, LLC | $123.11 | 2019 | |
| Terumo Bct, INC. | $75.84 | 2020 | |
| Electronic Waveform Lab, INC. | $44.83 | 2022 | |
| Amgen INC. | $29.99 | 2024 | Prolia, Evenity |
| Cerapedics INC. | $28.26 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Gs Solutions, INC. | $23.56 | 2023-2024 | |
| Heron Therapeutics, INC. | $22.99 | 2024 | Zynrelef |
| Xtant Medical INC | $22.12 | 2025 | |
| Misonix INC | $20.85 | 2019 | |
| Evolution Surgical, INC | $20.59 | 2020 | |
| Mml US, INC. | $18.85 | 2023 | Reactiv8 |
| Integra Lifesciences Corporation | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,302.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.